2nd Circuit: Relators In Cancer Drug False Claim Case Weren’t ‘Original Sources’

(March 29, 2023, 1:30 PM EDT) -- NEW YORK — A panel of the Second Circuit U.S. Court of Appeals on March 28 affirmed dismissal of a whistleblower lawsuit in which two relators alleged that an oncology treatment network accepted kickbacks from cancer drug suppliers and then submitted false claims to federal health care programs, agreeing with a district court that the plaintiffs were not the original source of information about the alleged wrongdoing....